Abstract
ObjectiveTo report the efficacy, patient-reported, radiographic and safety outcomes of 4 years’ certolizumab pegol (CZP) treatment in patients with psoriatic arthritis (PsA).MethodsRAPID-PsA (NCT01087788) was double-blind and placebo-controlled to Week 24,...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have